In situ product removal using a crystallization loop in asymmetric reduction of 4-oxoisophorone by Saccharomyces cerevisiae

被引:28
作者
Buque-Taboada, EM
Straathof, AJJ
Heijnen, JJ
van der Wielen, LAM
机构
[1] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands
[2] Univ San Carlos, Dept Chem Engn, Cebu, Philippines
关键词
4-oxoisophorone; bioreduction; in situ product removal; baker's yeast; crystallization;
D O I
10.1002/bit.20093
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
In situ product crystallization was investigated for solid product crystals that were obtained, during fermentation. The model reaction was the asymmetric reduction of 4-oxoisophorone (OIP) using baker's yeast (S. cerevisiae) as a biocatalyst. The target product was 6R-dihydro-oxoisophorone (DOIP), also known as levodione, a key intermediate in carotenoid synthesis. DOIP was-degraded by baker's yeast mainly to (4S,6R)-actinol, an unwanted byproduct in the process. Actinol formation reached up to 12.5% of the initial amount of OIP in the reactor during a batch process. However, better results were obtained when the dissolved DOIP concentration was controlled using an integrated fermentation-crystallization process because: (a) actinol formation was reduced to 4%; and (b) DOIP crystal formation in the reactor was avoided. DOIP productivity was improved by 50% and its selectivity was raised from 87% to 96% relative to the batch process. In the integrated process, most of the product was recovered as pure crystals; this may already minimize, if not eliminate, the need for organic solvents, in the final, purification steps. An almost sixfold reduction in biocatalyst consumption per kilogram product was achieved, which also can contribute to the minimization of waste streams. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:795 / 800
页数:6
相关论文
共 35 条
[1]
Optimal operation of an integrated bioreaction-crystallization process for continuous production of calcium gluconate using external loop airlift columns [J].
Bao, J ;
Koumatsu, K ;
Furumoto, K ;
Yoshimoto, M ;
Fukunaga, K ;
Nakao, K .
CHEMICAL ENGINEERING SCIENCE, 2001, 56 (21-22) :6165-6170
[2]
BLACKER AJ, 1997, CHIRALITY IND, V2, P245
[3]
Immobilization affects the rate and enantioselectivity of 3-oxo ester reduction by baker's yeast [J].
Buque, EM ;
Chin-Joe, I ;
Straathof, AJJ ;
Jongejan, JA ;
Heijnen, JJ .
ENZYME AND MICROBIAL TECHNOLOGY, 2002, 31 (05) :656-664
[4]
A SIMPLE-MODEL FOR THE OPTIMIZATION OF THE EXTRACTION YIELD OF ANTIBIOTICS ISOLATED FROM FERMENTED BROTHS BY DIRECT CRYSTALLIZATION [J].
CARDOSO, JP .
BIOTECHNOLOGY AND BIOENGINEERING, 1993, 42 (09) :1068-1076
[5]
Asymmetric bioreduction of (2-(4-nitro-phenyl)-N-(2-oxo-2-pyridin-3-yl-ethyl)-acetamide) to its corresponding (R) alcohol [(R)-N-(2-hydroxy-2-pyridin-3-yl-ethyl)-2-(4-nitro-phenyl)-acetamide] by using Candida sorbophila MY 1833 [J].
Chartrain, M ;
Roberge, C ;
Chung, J ;
McNamara, J ;
Zhao, DL ;
Olewinski, R ;
Hunt, G ;
Salmon, P ;
Roush, D ;
Yamazaki, S ;
Wang, T ;
Grabowski, E ;
Buckland, B ;
Greasham, R .
ENZYME AND MICROBIAL TECHNOLOGY, 1999, 25 (06) :489-496
[6]
Effect of high product concentration in a dual fed-batch asymmetric 3-oxo ester reduction by baker's yeast [J].
Chin-Joe, I ;
Straathof, AJJ ;
Pronk, JT ;
Jongejan, JA ;
Heijnen, JJ .
BIOCATALYSIS AND BIOTRANSFORMATION, 2002, 20 (05) :337-345
[7]
Influence of the ethanol and glucose supply rate on the rate and enantioselectivity of 3-oxo ester reduction by baker's yeast [J].
Chin-Joe, I ;
Straathof, AJJ ;
Pronk, JT ;
Jongejan, JA ;
Heijnen, JJ .
BIOTECHNOLOGY AND BIOENGINEERING, 2001, 75 (01) :29-38
[8]
Chin-Joe I, 2000, BIOTECHNOL BIOENG, V69, P370, DOI 10.1002/1097-0290(20000820)69:4<370::AID-BIT3>3.0.CO
[9]
2-B
[10]
Synthesis of trimegestone: The first industrial application of bakers' yeast mediated reduction of a ketone [J].
Crocq, V ;
Masson, C ;
Winter, J ;
Richard, C ;
Lemaitre, Q ;
Lenay, J ;
Vivat, M ;
Buendia, J ;
Prat, D .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1997, 1 (01) :2-13